Tag Archives: HIV/Aids

Pharmaceuticals: South Africa Needs to Step Up to Protect Consumers

It could be as late as 2015 before South African consumers can expect any new protection from the pharmaceutical industry and its practice of “evergreening”. Evergreening is the industry term for a practice where pharmaceutical companies lodge modifications of existing drugs to secure a new patent, thus guaranteeing a new twenty-year monopoly and fighting off […]